Payments to Acquire Property, Plant, and Equipment of Denali Therapeutics Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Denali Therapeutics Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Denali Therapeutics Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $5,078,000, a 136% increase year-over-year.
  • Denali Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $9,502,000, a 40% decline from 2024.
  • Denali Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $15,912,000, a 23% increase from 2023.
  • Denali Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $12,939,000, a 27% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Denali Therapeutics Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $9,502,000 -$6,410,000 -40% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $15,912,000 +$2,973,000 +23% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $12,939,000 -$4,894,000 -27% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $17,833,000 +$9,333,000 +110% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $8,500,000 +$5,405,000 +175% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $3,095,000 -$14,824,000 -83% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $17,919,000 +$14,526,000 +428% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $3,393,000 +$518,000 +18% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $2,875,000 -$3,259,000 -53% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $6,134,000 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY

Denali Therapeutics Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $5,078,000 +$2,928,000 +136% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $2,150,000 -$636,000 -23% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $2,786,000 -$1,255,000 -31% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $4,041,000 +$1,241,000 +44% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $2,800,000 +$1,921,000 +219% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $879,000 -$1,149,000 -57% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $2,028,000 +$1,491,000 +278% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $537,000 -$331,000 -38% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $868,000 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.